By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AtheroNova Inc. 

PO Box 4198

Newport Beach  California    U.S.A.
Phone: 949-903-0468 Fax:



Company News
AtheroNova Inc. (AHRO.OB) Announces Pre-IND Filing Under Section 505(b)(2) 7/15/2014 6:34:14 AM
AtheroNova Inc. (AHRO.OB) Announces Russian Ministry Of Healthcare Approval For Initiation Of Phase 1b Trial Investigating AHRO-001 5/28/2014 9:06:41 AM
AtheroNova Inc. (AHRO.OB) Announces Q1 2014 Financial Results/Highlights 5/19/2014 9:39:17 AM
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 2nd US Patent 8,697,633 5/8/2014 10:08:56 AM
AtheroNova Inc. (AHRO.OB) 1-For-10 Reverse Stock Split Effective 4/22/2014 9:14:35 AM
AtheroNova Inc. (AHRO.OB) Appoints Dr. Randolph M. Johnson As Chief Operating Officer 4/8/2014 7:28:27 AM
AtheroNova Inc. (AHRO.OB) Announces 2013 Financial Results 3/6/2014 9:19:48 AM
AtheroNova Inc. (AHRO.OB) Announces Preliminary Positive Phase 1 Clinical Data From Lead Drug AHRO-001, A Potential Treatment For Atherosclerosis 2/27/2014 9:17:04 AM
AtheroNova Inc. (AHRO.OB) Completes Enrollment In Phase 1 Clinical Trial Of AHRO-001, A Potential Treatment For Atherosclerosis 12/5/2013 11:29:59 AM
Atherosclerosis Researcher Dr. Erik Stroes Joins AtheroNova Inc. (AHRO.OB)'s Clinical Advisory Board 10/15/2013 6:23:48 AM